These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 16725324

  • 21. Synthesis of pyrazinamide Mannich bases and its antitubercular properties.
    Sriram D, Yogeeswari P, Reddy SP.
    Bioorg Med Chem Lett; 2006 Apr 15; 16(8):2113-6. PubMed ID: 16464574
    [Abstract] [Full Text] [Related]

  • 22. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides.
    Sriram D, Yogeeswari P, Devakaram RV.
    Bioorg Med Chem; 2006 May 01; 14(9):3113-8. PubMed ID: 16412646
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and in-vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro- 8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids.
    Senthilkumar P, Dinakaran M, Chandraseakaran Y, Yogeeswari P, Sriram D.
    Arch Pharm (Weinheim); 2009 Feb 01; 342(2):100-12. PubMed ID: 19137533
    [Abstract] [Full Text] [Related]

  • 24. Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis.
    Castagnolo D, De Logu A, Radi M, Bechi B, Manetti F, Magnani M, Supino S, Meleddu R, Chisu L, Botta M.
    Bioorg Med Chem; 2008 Sep 15; 16(18):8587-91. PubMed ID: 18752962
    [Abstract] [Full Text] [Related]

  • 25. N1-phenyl substituted 4-quinolones of tuberculostatic activity.
    Holzgrabe U, Steinert M.
    Pharmazie; 2001 Nov 15; 56(11):850-1. PubMed ID: 11817167
    [Abstract] [Full Text] [Related]

  • 26. A facile four-component sequential protocol in the expedient synthesis of novel 2-aryl-5-methyl-2,3-dihydro-1H-3-pyrazolones in water and their antitubercular evaluation.
    Gunasekaran P, Perumal S, Yogeeswari P, Sriram D.
    Eur J Med Chem; 2011 Sep 15; 46(9):4530-6. PubMed ID: 21839549
    [Abstract] [Full Text] [Related]

  • 27. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.
    Ahsan MJ, Samy JG, Dutt KR, Agrawal UK, Yadav BS, Vyas S, Kaur R, Yadav G.
    Bioorg Med Chem Lett; 2011 Aug 01; 21(15):4451-3. PubMed ID: 21733688
    [Abstract] [Full Text] [Related]

  • 28. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis.
    Dinakaran M, Senthilkumar P, Yogeeswari P, Sriram D.
    Biomed Pharmacother; 2009 Jan 01; 63(1):11-8. PubMed ID: 18078735
    [Abstract] [Full Text] [Related]

  • 29. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
    Gemma S, Savini L, Altarelli M, Tripaldi P, Chiasserini L, Coccone SS, Kumar V, Camodeca C, Campiani G, Novellino E, Clarizio S, Delogu G, Butini S.
    Bioorg Med Chem; 2009 Aug 15; 17(16):6063-72. PubMed ID: 19620006
    [Abstract] [Full Text] [Related]

  • 30. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D, Manetti F, Radi M, Bechi B, Pagano M, De Logu A, Meleddu R, Saddi M, Botta M.
    Bioorg Med Chem; 2009 Aug 01; 17(15):5716-21. PubMed ID: 19581099
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Synthesis and discovery of new bisadducts derived from heterocyclic aldehydes and active methylene compounds as potent antitubercular agents.
    Asad M, Oo CW, Kumar RS, Osman H, Ali MA.
    Acta Pol Pharm; 2013 Aug 01; 70(2):221-8. PubMed ID: 23614277
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
    Sriram D, Yogeeswari P, Dinakaran M, Thirumurugan R.
    J Antimicrob Chemother; 2007 Jun 01; 59(6):1194-6. PubMed ID: 17449482
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Synthesis and optimization of antitubercular activities in a series of 4-(aryloxy)phenyl cyclopropyl methanols.
    Bisht SS, Dwivedi N, Chaturvedi V, Anand N, Misra M, Sharma R, Kumar B, Dwivedi R, Singh S, Sinha SK, Gupta V, Mishra PR, Dwivedi AK, Tripathi RP.
    Eur J Med Chem; 2010 Dec 01; 45(12):5965-78. PubMed ID: 20970222
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
    Hearn MJ, Cynamon MH.
    J Antimicrob Chemother; 2004 Feb 01; 53(2):185-91. PubMed ID: 14688045
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.